Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher to Offer Senior Notes

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today filed a registration statement with the US Securities and Exchange Commission to offer senior notes to fund its acquisition of Dionex, as well as for general corporate purposes.

Details of the offering have yet to be determined, including the total amount Thermo Fisher is seeking to raise, other than the firm's intention offer three sets of senior notes due 2014, 2016, and 2021, respectively.

Thermo Fisher signed an agreement in December to acquire chromatography technologies firm Dionex for approximately $2.1 billion.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.